Switching Perfusion Agents for Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Surgical Dogma or Evidence-Based Practice?

Christopher W MangieriCristian D ValenzuelaIan B SolskyRichard A EraliKonstantinos I VotanopoulosPerry ShenEdward A Levine

Published in: Annals of surgical oncology (2022)

The study findings revealed no survival benefit with switching perfusion agents. Analysis suggests that the practice of perfusion switch is ineffective.

Keyphrases

contrast enhanced
minimally invasive
healthcare
primary care
coronary artery bypass
magnetic resonance imaging
single cell
magnetic resonance
quality improvement
coronary artery disease
metastatic renal cell carcinoma
data analysis